ArticleJournal of translational medicine2023

CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (

Joana Grand-Guillaume et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.